JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsao, L.-I
Right arrow Articles by Su, T.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsao, L.-I
Right arrow Articles by Su, T.-P.

Vol. 287, Issue 1, 322-331, October 1998

Delta Opioid Peptide [D-Ala2,D-leu5]Enkephalin Blocks the Long-term Loss of Dopamine Transporters Induced by Multiple Administrations of Methamphetamine: Involvement of Opioid Receptors and Reactive Oxygen Species

Li-I Tsao, Bruce Ladenheim, Anne M. Andrews, Chuang C. Chiueh, Jean Lud Cadet and Tsung-Ping Su

Molecular Neuropsychiatry Section, Cellular Neurobiology Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore and Laboratory of Clinical Science, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland

Delta opioid peptide [D-Ala2,D-leu5]enkephalin (DADLE) can prolong organ preservation and increases myocardial tolerance to ischemia. Our study examined the protective property of DADLE against methamphetamine- (METH) induced dopaminergic terminal damage in the central nervous system. Because the neurotoxicity of METH involves reactive oxygen species, we also examined if DADLE might be an antioxidative agent in vitro. DADLE at 2 and 4 mg/kg (i.p.), given 30 min before each METH administration (5 or 10 mg/kg, i.p., four injections in a day at 2-hr intervals), dose-dependently blocked the METH-induced long-term dopamine transporter loss. The opioid antagonist naltrexone blocked this action of DADLE in both aspects of striata but tends not to affect the effects of DADLE in the nucleus accumbens. DADLE did not alter changes in body temperature induced by METH. The reduction of striatal dopaminergic content and tyrosine hydroxylase activity caused by METH, however, were not blocked by DADLE. In vitro, DADLE was approximately equipotent to glutathione in inhibiting both superoxide anion formation induced by xanthine oxidase and hydroxyl radical formation evoked by ferrous/citrate complex. DADLE was only slightly less potent than glutathione in inhibiting the iron/ascorbate-induced brain lipid peroxidation. These results suggest that DADLE can protect the terminal membranes of dopaminergic neurons against METH-induced insult but not the loss of dopaminergic content and tyrosine hydroxylase activity and that this action of DADLE might involve opioid receptors as well as the sequestration of free radical.

0022-3565/98/2871-0322$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
M. Iwata, S. Inoue, M. Kawaguchi, M. Nakamura, N. Konishi, and H. Furuya
Effects of delta-opioid receptor stimulation and inhibition on hippocampal survival in a rat model of forebrain ischaemia
Br. J. Anaesth., October 1, 2007; 99(4): 538 - 546.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. P. Rao, C. Yuan, J. C. Allegood, S. S. Rawat, M. B. Edwards, X. Wang, A. H. Merrill Jr., U. Acharya, and J. K. Acharya
Ceramide transfer protein function is essential for normal oxidative stress response and lifespan
PNAS, July 3, 2007; 104(27): 11364 - 11369.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
E. M. Jutkiewicz
The Antidepressant -like Effects of Delta-Opioid Receptor Agonists
Mol. Interv., June 1, 2006; 6(3): 162 - 169.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. H. Kim, S. J. Won, X. O. Mao, K. Jin, and D. A. Greenberg
Involvement of Protein Kinase A in Cannabinoid Receptor-Mediated Protection from Oxidative Neuronal Injury
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 88 - 94.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
T. Horiuchi, M. Kawaguchi, T. Sakamoto, N. Kurita, S. Inoue, M. Nakamura, N. Konishi, and H. Furuya
The Effects of the {delta}-Opioid Agonist SNC80 on Hind-Limb Motor Function and Neuronal Injury After Spinal Cord Ischemia in Rats
Anesth. Analg., July 1, 2004; 99(1): 235 - 240.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
Y. Wang, T. Hayashi, C.-F. Chang, Y.-H. Chiang, L.-I Tsao, T.-P. Su, C. Borlongan, and S.-Z. Lin
Methamphetamine Potentiates Ischemia/Reperfusion Insults After Transient Middle Cerebral Artery Ligation
Stroke, March 1, 2001; 32(3): 775 - 782.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
D. M. Kuhn, C. W. Aretha, and T. J. Geddes
Peroxynitrite Inactivation of Tyrosine Hydroxylase: Mediation by Sulfhydryl Oxidation, not Tyrosine Nitration
J. Neurosci., December 1, 1999; 19(23): 10289 - 10294.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
X. Deng, B. Ladenheim, L.-I Tsao, and J. L. Cadet
Null Mutation of c-fos Causes Exacerbation of Methamphetamine-Induced Neurotoxicity
J. Neurosci., November 15, 1999; 19(22): 10107 - 10115.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.